Loading...
By Amy Orciari Herman
Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD
Adding whole-genome sequencing to standard family history taking "reveals new molecular findings of uncertain clinical utility" and "may prompt additional clinical actions of unclear value," researchers conclude in the Annals of Internal Medicine.
One hundred healthy primary care patients (age 40–65) were randomized to provide a family history alone or to also undergo whole genome sequencing. Their physicians received brief training in management of genomic sequencing results.
In the sequencing group, 11 of 50 patients were found to have a previously unrecognized variant suggesting risk for a Mendelian disease; of these, just 2 showed symptoms related to the variant (fundus albipunctatus and variegate porphyria). All 50 patients had variants associated with recessive conditions.
During 6 month's follow-up, more patients in the genomic sequencing group (versus family history group) made health behavior changes. Genomic sequencing was tied to greater subsequent healthcare use and costs.
Geneticists rated primary care physician management of genomic results as appropriate in most cases.
Comment
LINK(S):
Annals of Internal Medicine article (Free abstract)
Annals of Internal Medicine editorial (Subscription required)
Background: NEJM Journal Watch General Medicine coverage of whole genome sequencing in clinical medicine (Your NEJM Journal Watch registration required)